Literature DB >> 12766472

The mitochondrial membrane potential (deltapsi(m)) in apoptosis; an update.

J D Ly1, D R Grubb, A Lawen.   

Abstract

Mitochondrial dysfunction has been shown to participate in the induction of apoptosis and has even been suggested to be central to the apoptotic pathway. Indeed, opening of the mitochondrial permeability transition pore has been demonstrated to induce depolarization of the transmembrane potential (deltapsi(m)), release of apoptogenic factors and loss of oxidative phosphorylation. In some apoptotic systems, loss of deltapsi(m) may be an early event in the apoptotic process. However, there are emerging data suggesting that, depending on the model of apoptosis, the loss of deltapsi(m) may not be an early requirement for apoptosis, but on the contrary may be a consequence of the apoptotic-signaling pathway. Furthermore, to add to these conflicting data, loss of deltapsi(m) has been demonstrated to not be required for cytochrome c release, whereas release of apoptosis inducing factor AIF is dependent upon disruption of deltapsi(m) early in the apoptotic pathway. Together, the existing literature suggests that depending on the cell system under investigation and the apoptotic stimuli used, dissipation of deltapsi(m) may or may not be an early event in the apoptotic pathway. Discrepancies in this area of apoptosis research may be attributed to the fluorochromes used to detect deltapsi(m). Differential degrees of sensitivity of these fluorochromes exist, and there are also important factors that contribute to their ability to accurately discriminate changes in deltapsi(m).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12766472     DOI: 10.1023/a:1022945107762

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  389 in total

1.  Effect of sesquiterpene lactone coronopilin on leukaemia cell population growth, cell type-specific induction of apoptosis and mitotic catastrophe.

Authors:  R Cotugno; R Fortunato; A Santoro; D Gallotta; A Braca; N De Tommasi; M A Belisario
Journal:  Cell Prolif       Date:  2011-12-14       Impact factor: 6.831

2.  Synthesis and evaluation of 1,5-disubstituted tetrazoles as rigid analogues of combretastatin A-4 with potent antiproliferative and antitumor activity.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Maria Kimatrai Salvador; Delia Preti; Mojgan Aghazadeh Tabrizi; Andrea Brancale; Xian-Hua Fu; Jun Li; Su-Zhan Zhang; Ernest Hamel; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2011-12-21       Impact factor: 7.446

3.  A translocator protein ligand PK11195 shows antigrowth activity in human choriocarcinoma cells.

Authors:  Noriyuki Takai; Naoko Kira; Terukazu Ishii; Toshie Yoshida; Masakazu Nishida; Yoshihiro Nishida; Kaei Nasu; Masayuki Takano; Haruna Midori; Satoko Koga; Hisashi Narahara
Journal:  Tumour Biol       Date:  2012-04-20

4.  MG-2477, a new tubulin inhibitor, induces autophagy through inhibition of the Akt/mTOR pathway and delayed apoptosis in A549 cells.

Authors:  Giampietro Viola; Roberta Bortolozzi; Ernest Hamel; Stefano Moro; Paola Brun; Ignazio Castagliuolo; Maria Grazia Ferlin; Giuseppe Basso
Journal:  Biochem Pharmacol       Date:  2011-09-22       Impact factor: 5.858

5.  Synthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Andrea Brancale; Ernest Hamel; Longchuan Chen; Roberta Bortolozzi; Giuseppe Basso; Giampietro Viola
Journal:  J Med Chem       Date:  2010-05-27       Impact factor: 7.446

6.  Symmetrical alpha-bromoacryloylamido diaryldienone derivatives as a novel series of antiproliferative agents. Design, synthesis and biological evaluation.

Authors:  Romeo Romagnoli; Pier Giovanni Baraldi; Olga Cruz-Lopez; Carlota Lopez Cara; Maria Dora Carrion; Jan Balzarini; Ernest Hamel; Giuseppe Basso; Roberta Bortolozzi; Giampietro Viola
Journal:  Bioorg Med Chem Lett       Date:  2010-03-25       Impact factor: 2.823

7.  Mitochondria are the primary target in the induction of apoptosis by chiral ruthenium(II) polypyridyl complexes in cancer cells.

Authors:  Jin-Quan Wang; Ping-Yu Zhang; Chen Qian; Xiao-Juan Hou; Liang-Nian Ji; Hui Chao
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

8.  Sijunzi decoction-treated rat serum induces apoptosis of side population cells in gastric carcinoma.

Authors:  Jianguang Jia; Yiyu Qin; Ligong Zhang; Chenxu Guo; Yaguo Wang; Xicheng Yue; Jun Qian
Journal:  Exp Ther Med       Date:  2017-11-24       Impact factor: 2.447

9.  Discovery of Highly Potent 2-Sulfonyl-Pyrimidinyl Derivatives for Apoptosis Inhibition and Ischemia Treatment.

Authors:  Li Li; Xian Jiang; Shaoqiang Huang; Zhengxin Ying; Zhaolan Zhang; Chenjie Pan; Sisi Li; Xiaodong Wang; Zhiyuan Zhang
Journal:  ACS Med Chem Lett       Date:  2017-03-01       Impact factor: 4.345

10.  Manipulating the mitochondria activity in human hepatic cell line Huh7 by low-power laser irradiation.

Authors:  Anna Lynnyk; Mariia Lunova; Milan Jirsa; Daria Egorova; Andrei Kulikov; Šárka Kubinová; Oleg Lunov; Alexandr Dejneka
Journal:  Biomed Opt Express       Date:  2018-02-21       Impact factor: 3.732

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.